Speakers

Michael Asbach, DMSc, PA-C, serves as Associate Director of Interventional Psychiatry at DENT Neurologic Institute, where he oversees the delivery of innovative and evidence-based treatments for patients with complex and refractory mental health conditions. With more than 12 years of experience as a board-certified psychiatric physician assistant and a doctor of medical science in healthcare leadership, Asbach is dedicated to advancing the field of mental health care. In addition, Asbach holds the role of medical liaison to the American Psychiatric Association on behalf of the American Academy of Physician Associates.

As Co-Founder of The Non-Clinical Collective, Asbach leads a medical education platform designed to support healthcare professionals in their non-clinical career development and wellness. Through this platform, Asbach shares a deep passion for mental health advocacy, education, and engaging with a diverse and active audience. The mission is to foster a community where individuals can achieve meaningful and fulfilling careers through education and empowerment.

Combining a doctor of medical science degree in healthcare leadership with extensive clinical experience, Asbach integrates expertise in healthcare policy, the business of medicine, and continuing education. A nationally recognized educator, Asbach is actively involved in several professional organizations, including the American Academy of Physician Associates and the Association of Physician Assistants in Psychiatry. Their work reflects a commitment to excellence, leadership, and advocacy within the healthcare community.

Christoph U. Correll, MD, is Professor of Psychiatry at the Zucker School of Medicine at Hofstra/Northwell in New York and Professor and Chair of the Department of Child and Adolescent Psychiatry at Charité University Medicine in Berlin, Germany. He completed his medical studies at the Free University of Berlin in Germany and University of Dundee School of Medicine in Scotland. He is board certified in general psychiatry and child and adolescent psychiatry, having completed both residencies at the Zucker Hillside Hospital in New York. Since 1997, he has been working and conducting research in New York, and since 2017 he is also working in Germany again.  

Dr. Correll focuses on the identification and treatment of youth and adults with severe mental illness, including schizophrenia, mood disorders, aggression spectrum disorders, and eating disorders, in addition to clinical trials, epidemiology, psychopharmacology, meta-analyses, and the interface between physical health and mental health.  

He has authored or co-authored over 1,000 journal articles that have been cited more than 92,000 times and has received over 40 research awards for his work. In May 2025, his h-index was 154 on Google Scholar. Since 2014, the beginning of this metric, he has been listed every year by Clarivate/Web of Science as being one of the “most influential scientific minds” and in the top 1% of cited scientists in the area of psychiatry. Additionally, he holds numerous Expertscape rankings based on the number of publications and citations in the past 10 years, ie, for 15 topics as “Expert” (among the top 1% of cited scientists) and 24 topics as “World Expert” (among the top 0.1% of cited scientists), including being ranked in May 2025 as number one among World Experts for the following areas:

1. Central nervous system depressants, out of 259,989 ranked scientists
2. Psychotropic drugs, out of 138,731 ranked scientists
3. Schizophrenia, out of 101,038 ranked scientists
4. Schizophrenia spectrum and other psychotic disorders, out of 121,673 ranked scientists
5. Antipsychotics, out of 56,247 ranked scientists
6. Olanzapine, out of 10,235 ranked scientists
7. Delayed action preparations, out of 69,531 ranked scientists
8. Tranquilizing agents, out of 72,377 ranked scientists
9. Weight gain, out of 76,380 ranked scientists
   

Hara E. Oyedeji, PMHNP-BC, APRN, MSN, MSEd, is a board-certified psychiatric-mental health nurse practitioner currently working in outpatient care who has experience in inpatient and psychiatric hospital settings. She is Founder and Lead Clinician of her private practice, Fortitude Wellness Group, and is the Chief Operating Officer and Medical Director of a CARF-accredited outpatient mental health clinic, Greater Chesapeake Health and Wellness in Baltimore, Maryland. Oyedeji completed her undergraduate degree at Rutgers University and her master’s degree in education at Monmouth University in New Jersey. She completed her master’s degree in nursing at the University of Maryland and her post-master’s training as a psychiatric-mental health nurse practitioner at Drexel University.

Her areas of expertise include severe mental illness and psychotic disorders for high-risk populations, and she treats across the lifespan, from children to adults. She also provides medication-assisted treatment for patients with co-occurring mental health and substance use disorders. As a national speaker and key opinion leader, she has presented on disease states and pharmacology for mental health. This includes clinical perspectives of and approved treatment options for schizophrenia, bipolar disorder, depression, and drug-induced movement disorders. She has presented at various conferences, including the Nurse Practitioner Institute (NPI), American Association of Nurse Practitioners (AANP), American Psychiatric Nurses Association (APNA), and Nurse Practitioners Association of Maryland (NPAM), of which she is also an active member.

Oyedeji is a sitting board member for the nonprofit organization Abilities Network, which is committed to individualized community support for children, families, and those with developmental disabilities. As an advocate for self-care and mental health issues affecting marginalized communities, Oyedeji is committed to health equity and inspired by family members thriving in their journeys.

Stephen M. Stahl, MD, PhD, DSc (Hon), received his undergraduate and medical degrees from Northwestern University in Chicago as a member of the Honors Program in Medical Education and his PhD in pharmacology and physiology from the University of Chicago. Dr. Stahl has trained in three specialties: internal medicine at the University of Chicago; neurology at the University of California, San Francisco; and psychiatry at Stanford University. He is board certified in psychiatry.

Dr. Stahl has held faculty positions at Stanford University; the University of California, Los Angeles (UCLA); the Institute of Psychiatry, London; and the Institute of Neurology, London. He is currently Distinguished Clinical Professor of Psychiatry and Neuroscience at the University of California, Riverside (UC Riverside); Adjunct Professor of Psychiatry at the University of California San Diego (UCSD) and the State University of New York Upstate Medical University in Syracuse; and Honorary Visiting Senior Fellow at the University of Cambridge in the UK. He also directs psychopharmacology services and academic programs for the five-facility, 6,500-patient California Department of State Hospitals, where he has a leadership role in addressing violence and decriminalization of the seriously mentally ill. Dr. Stahl was formerly Executive Director of Clinical Neurosciences at the Merck Neuroscience Research Center in the UK for several years. His major interests are dedicated to producing and disseminating educational information about diseases and their treatments in psychiatry and neurology.

Dr. Stahl is Editor Emeritus of CNS Spectrums, past Associate Editor of Acta Psychiatrica Scandinavica, former Clinical Field Editor for The International Journal of Neuropsychopharmacology, and has been and is currently on numerous editorial boards of other leading journals, including the American College of Neuropsychopharmacology (ACNP)’s journal Neuropsychopharmacology. During his career, he has conducted numerous research projects awarded by the National Institute of Mental Health (NIMH), the Department of Veterans Affairs (VA), and the pharmaceutical industry. Author of 600 articles and chapters with an h-index of 75 and more than 2,000 scientific presentations and abstracts, Dr. Stahl is an internationally renowned clinician, researcher, and teacher in psychiatry with subspecialty expertise in psychopharmacology. Dr. Stahl has written over 60 textbooks and edited 15 others, including the best-selling and award-winning textbook Stahl’s Essential Psychopharmacology: Neuroscientific Basis and Practical Applications, now in its fifth edition, and the best-selling and award-winning clinical manual Prescriber’s Guide: Stahl’s Essential Psychopharmacology, now in its eighth edition. Dr. Stahl has also published a novel, Shell Shock, a thriller that recounts the history of posttraumatic stress disorder (PTSD), and a biography of Nikola Tesla, showing the interaction of Tesla’s bipolar disorder with his genius. Lectures, courses, and preceptorships based upon his textbooks have taken him to dozens of countries on six continents to speak to tens of thousands of physicians, mental health professionals, and students at all levels. His books have sold over a million copies, and his lectures and scientific presentations have been distributed to hundreds of thousands of professionals in many different languages. His courses and award-winning multimedia teaching materials are used by psychopharmacology teachers and students throughout the world. Dr. Stahl serves as a Fellow of the ACNP, the British Association of Psychopharmacology (BAP), and the International College of Neuropsychopharmacology (CINP), where he was formerly Vice President, and is a Distinguished Life Fellow of the American Psychiatric Association (APA). He has also served on numerous medical and scientific advisory boards for the pharmaceutical industry, the biotechnology and medical information industry, and various nonprofit and public service organizations, including as past Chair of the State of California’s Medi-Cal Oversight Board for Medicines (Drug Utilization Review Board).

He has been awarded the CINP Lundbeck Foundation Award in Education for his contributions to postgraduate education in psychiatry and neurology, the Aristotle Gold Medal from Greece, the Sapienza University of Rome Award, and the Paykel Lecture from Cambridge University, all for his lifetime achievements in psychiatry. His books have won the British Medical Association’s Book of the Year Award, which he received again in 2022 for his handbook on suicide prevention, and he received the First Place Award for his digital master class in psychopharmacology, accredited by Cambridge University Health Partners and the Department of Psychiatry at the University of Cambridge. His continuing medical education (CME) institute, the Neuroscience Education Institute (NEI), has been awarded accreditation with commendation, and his medical education company, Arbor Scientia, has been awarded the Business of the Year Award from the local chamber of commerce. Dr. Stahl is also the winner of the A.E. Bennett Award of the Society of Biological Psychiatry, the APA/San Diego Psychiatric Society Education Award, and the UCSD Department of Psychiatry Residency and UC Riverside Department of Psychiatry and Neuroscience Teaching Awards. In addition, he has been cited as both one of “America’s Top Psychiatrists” and one of the “Best Doctors in America.” He was honored with the Distinguished Psychiatrist Award of the APA and gave the Distinguished Psychiatrist Lecture for 2013. His alma mater Northwestern University has honored him by naming their annual award for the best medical student going into psychiatry the “Stephen Stahl Award.” Dr. Stahl was named the 2016 David A. Mrazek Memorial Award winner by the APA and delivered the Mrazek Lecture at the 2016 Annual Meeting of the APA. In 2018, he was awarded an honorary doctor of science degree by Üsküdar University in Istanbul. In 2018, Dr. Stahl was invited by the Vatican in Rome to co-found the School of Psychopharmacology, Psychopharmacology and Neuroethics at the Vatican’s European University of Rome in Vatican City to deal with policy issues to lessen the burden of the seriously mentally ill by bringing together leaders in psychiatry under the auspices of Pope Francis, along with world leaders from government and academia. In 2024, Dr. Stahl was awarded an honorary doctorate (doctor of medical sciences, honoris causa) by the University of Cambridge.